Your browser doesn't support javascript.
loading
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato, Stefano; Kahn, Steven E; Pavo, Imre; Weerakkody, Govinda J; Yang, Zhengyu; Doupis, John; Aizenberg, Diego; Wynne, Alan G; Riesmeyer, Jeffrey S; Heine, Robert J; Wiese, Russell J.
Afiliación
  • Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Electronic address: stefano.delprato@unipi.it.
  • Kahn SE; VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA. Electronic address: skahn@uw.edu.
  • Pavo I; Eli Lilly and Company, Indianapolis, IN, USA.
  • Weerakkody GJ; Eli Lilly and Company, Indianapolis, IN, USA.
  • Yang Z; Eli Lilly and Company, Indianapolis, IN, USA.
  • Doupis J; Iatriko Palaiou Falirou Medical Center, Athens, Greece.
  • Aizenberg D; Centro Médico Viamonte, Buenos Aires, Argentina.
  • Wynne AG; Cotton O'Neil Diabetes and Endocrinology Center, Topeka, KS, USA.
  • Riesmeyer JS; Eli Lilly and Company, Indianapolis, IN, USA.
  • Heine RJ; Eli Lilly and Company, Indianapolis, IN, USA.
  • Wiese RJ; Eli Lilly and Company, Indianapolis, IN, USA.
Lancet ; 398(10313): 1811-1824, 2021 11 13.
Article en En | MEDLINE | ID: mdl-34672967
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polipéptido Inhibidor Gástrico / Diabetes Mellitus Tipo 2 / Insulina Glargina Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polipéptido Inhibidor Gástrico / Diabetes Mellitus Tipo 2 / Insulina Glargina Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido